Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
QuintilesIMS
US Department of Justice
Covington
Mallinckrodt
Healthtrust
Cipla
McKesson
Dow
Colorcon

Generated: October 22, 2017

DrugPatentWatch Database Preview

LOTENSIN Drug Profile

« Back to Dashboard

Which patents cover Lotensin, and what generic Lotensin alternatives are available?

Lotensin is a drug marketed by Us Pharms Holdings I and is included in two NDAs.

The generic ingredient in LOTENSIN is benazepril hydrochloride; hydrochlorothiazide. There are fourteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the benazepril hydrochloride; hydrochlorothiazide profile page.

Summary for Tradename: LOTENSIN

US Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list48
Clinical Trials: see list10
Patent Applications: see list1,432
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LOTENSIN at DailyMed

Pharmacology for Tradename: LOTENSIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-001Jun 25, 1991ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-004May 19, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-004Jun 25, 1991ABRXYesYes► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-003May 19, 1992ABRXYesYes► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-002Jun 25, 1991ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-003Jun 25, 1991ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-002May 19, 1992ABRXYesNo► Subscribe► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN HCT
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL020033-001May 19, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LOTENSIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-001Jun 25, 1991► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-003Jun 25, 1991► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-004Jun 25, 1991► Subscribe► Subscribe
Us Pharms Holdings I
LOTENSIN
benazepril hydrochloride
TABLET;ORAL019851-002Jun 25, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Accenture
Healthtrust
Queensland Health
Cerilliant
Chubb
Fuji
UBS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot